Thermochemotherapy for Unresectable Hepatic Cancer
The prognosis of unresectable neoplastic disease of the liver, whether primary or metastatic, remains poor. Current methods of treatment are unsatisfactory. The use of standard systemic chemotherapy has resulted in objective tumor responses to 7%–45% of patients so treated [1, 2]. Hepatic artery infusion of chemotherapeutic drugs has allowed for higher response rates of 30%–60% [3–5] but this is an invasive technique and its effect on survival is unclear. Regional radiofrequency hyperthermia (RFHT) has been used to treat deep tumors of the chest, abdomen, and pelvis [6–8] and has been used in combination with hepatic arterial obliteration and intratumor injection of cytotoxic drugs  and in combination with internal radiation .
KeywordsToxicity Catheter Rubber Oncol Doxorubicin
Unable to display preview. Download preview PDF.
- 8.Moffat FL, Falk RE, Calhoun F, Langer JC, Dreznik A, Makowka L, Rotstein LE, Ambus A, Howard V, Campbell A, Laing D, Venturi D, Falk JA (1983) The effect of radiofrequency hyperthermia and chemotherapy on primary and secondary hepatic malignancies when used with metronidazole. Surgery 94 (4): 536–542PubMedGoogle Scholar
- 9.LeVeen HH, Rajajopalan PR, Vryui I, Gobies RP, O’Brien PH, Hutto R, Pontiygian P, d’Ovidio N, Pethig R, Armitage D (1984) Radiofrequency thermotherapy, local thermotherapy, and arterial occlusion in the treatment of nonresectable cancer. Am Surg 59 (2): 61–65Google Scholar
- 18.Moertel CG (1978) Chemotherapy of colorectal cancer. In: Grundmann E (ed) Colon cancer. Fischer, New York, pp 207–216Google Scholar
- 19.Bengrah S, Hobstion L (1969) The natural history of primary and secondary malignant tumors of the liver: I: the program for patients with hepatic metastases from colon and rectal carcinoma by laparotomy. Cancer 192–202Google Scholar